Free Trial

Conduit Pharmaceuticals (CDT) SEC Filings & 10K Form

Conduit Pharmaceuticals logo
$4.72 -1.03 (-17.91%)
Closing price 04:00 PM Eastern
Extended Trading
$4.76 +0.04 (+0.85%)
As of 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Conduit Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/16/2025
7:45 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
4:35 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Sarborg Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/07/2025
4:36 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Sarborg Ltd (Filed by)
Form SCHEDULE 13G
05/06/2025
3:30 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
11:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
04/25/2025
3:30 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
4:24 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/17/2025
3:05 PM
Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
4:14 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form PRE 14A
04/10/2025
5:00 AM
ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Form SCHEDULE 13G/A
04/01/2025
8:04 PM
Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:07 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:09 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:13 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:23 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
3:54 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2025
3:30 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
03/06/2025
7:30 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
3:32 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SCHEDULE 13G/A
02/19/2025
8:00 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
02/12/2025
11:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
02/11/2025
7:00 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
4:19 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/06/2025
7:58 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
02/05/2025
4:30 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/23/2025
7:15 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SCHEDULE 13G
01/15/2025
3:30 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
12/20/2024
4:05 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2024
4:06 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:06 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:06 PM
Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:06 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
4:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
4:01 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
12/09/2024
7:30 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEF 14A
12/08/2024
11:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
12/09/2024
5:11 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
11/26/2024
4:21 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form PRE 14A
11/25/2024
4:10 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Revolution we predicted has arrived." In fact, I believe these robots could impact 65 million Americans lives — by August of this year.

I'll tell you more about the $7 company Huang and Nvidia joined forces with to make it happen.
11/25/2024
3:53 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:20 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:22 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q/A
11/14/2024
4:24 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q/A
11/14/2024
4:27 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
5:01 AM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
St George Street Capital (Filed by)
Form SC 13G/A
11/04/2024
4:20 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
11/04/2024
4:21 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
11/03/2024
11:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
11/01/2024
4:10 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEFA14A
11/01/2024
3:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
4:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEF 14A
10/28/2024
4:16 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEFA14A
10/28/2024
4:17 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form ARS
10/24/2024
5:12 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/18/2024
3:15 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SC 13G/A
10/16/2024
4:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form PRE 14A
10/15/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
5:01 AM
ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Form SC 13G
10/07/2024
6:36 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SC 13G/A
10/07/2024
6:38 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:02 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:59 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Corvus Capital Ltd. (Filed by)
Form SC 13D/A
09/19/2024
4:01 PM
Algo Holdings, Inc. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:41 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
09/16/2024
11:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
09/06/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
3:44 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/19/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
08/16/2024
3:59 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:29 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:30 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
4:53 PM
Bligh James (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:56 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CDT) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners